George Yancopoulos, EVP, CSO, & President Regn Res Labs at REGENERON PHARMACEUTICALS INC (REGN), sold 30,000 shares at $20.07 ($598K) on 2007-01-03, disclosed to the SEC on 2007-01-05.
Scheduled sale ($598k) by EVP, CSO, & President Regn Res Labs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.69 | 4,957 | $98K | 16.3% |
| 2 | $19.69 | 2,038 | $40K | 6.7% |
| 3 | $20.00 | 11,066 | $221K | 37.0% |
| 4 | $20.01 | 200 | $4K | 0.7% |
| 5 | $20.03 | 3,800 | $76K | 12.7% |
| 6 | $20.05 | 957 |
| $19K |
| 3.2% |
| 7 | $20.07 | 200 | $4K | 0.7% |
| 8 | $20.08 | 2,900 | $58K | 9.7% |
| 9 | $20.00 | 600 | $12K | 2.0% |
| 10 | $20.00 | 3,282 | $66K | 11.0% |
| Total | $19.94 avg | 30,000 | $598K | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |